Photo: depositphotos.com
Feb 4, 2026, 16:55
Bhavesh Thakkar: The Most Dangerous Assumption About Aspirin Is That It’s “Simple”
Bhavesh Thakkar, Clinical Pharmacist Intern at Fortis Healthcare, shared a post on LinkedIn:
”The most dangerous assumption we make about Aspirin? That it’s ‘simple.’
During my rotations at Fortis, I’ve realized that Aspirin is perhaps the most misunderstood drug on the shelf.
We often treat it as a basic NSAID. But the data tells a much more complex story.
From ancient willow bark to the modern debates on primary prevention, the ‘Story of Aspirin’ is actually a lesson in how evidence-based medicine evolves.
I put together this timeline to track that journey.
Inside this breakdown:
- The ‘Willow Bark’ origins (long before Bayer).
- How it changed the way we treat inflammation.
- The shift in guidelines: Why ‘routine’ use is now being questioned.
- Slide 12 was the biggest realization for me regarding the risk/benefit ratio in modern practice.
Pharmacists and Medics:
When do you still recommend Aspirin for primary prevention? Or have you stopped completely?”
Stay informed with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke